Original language | English |
---|---|
Number of pages | 3 |
Journal | Circulation |
Volume | 140 |
Publication status | Published - 19-Nov-2019 |
Event | Scientific Sessions of the American-Heart-Association - Philadelphia, Panama Duration: 16-Nov-2019 → 18-Nov-2019 |
Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c < 7%: Results From the CREDENCE Trial
Christopher P. Cannon, Vlado Perkovic, Rajiv Agarwal, James Baldassarre, George L. Bakris, Barry M. Brenner, David Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J. Lambers Heerspink, Meg Jardine, Adeera Levin, Jing-Wei Li, Bruce Neal, Carol Pollock, David Wheeler, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey
Research output: Contribution to journal › Meeting Abstract › Academic